Topiramate Capsule, Extended Release
Product Images NDC 68382-358

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68382-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1ecf8c84 2838 464e 87cd 96511278d9e7 01

Chemical structure of topiramate, depicting its bicyclic ring system with multiple oxygen atoms and a sulfamate functional group. The diagram shows the molecular arrangement relevant to the active ingredient topiramate.*

FDA Label Image

1ecf8c84 2838 464e 87cd 96511278d9e7 02

A line graph showing cumulative rates for time to first seizure over days. It compares two dosage groups of Topiramate: 50 mg/day and 400 mg/day, with cumulative rates plotted on the vertical axis and time in days on the horizontal axis.*

FDA Label Image

1ecf8c84 2838 464e 87cd 96511278d9e7 03

A bar graph displaying the change from baseline to double-blind phase in average monthly migraine period rate with placebo and three dosages of Topiramate extended release capsules (50 mg/day, 100 mg/day, and 200 mg/day). The graph compares results from two studies with error bars, showing dose-related reductions in migraine rate and statistical significance annotations.*

FDA Label Image

1ecf8c84 2838 464e 87cd 96511278d9e7 07

Topiramate 25 mg extended-release capsules label from Zydus Pharmaceuticals USA Inc. The label shows the dosage strength (25 mg), quantity (30 capsules), and form (hard gelatin capsules). It includes usage instructions to swallow capsules whole, storage conditions, and manufacturing details by Cadila Healthcare Ltd. in India. This prescription drug is for oral use and dispensed with medication guide information.*

FDA Label Image

1ecf8c84 2838 464e 87cd 96511278d9e7 08

Topiramate 50 mg extended-release capsules label showing the product as oral capsules for once daily use. The label includes directions to swallow whole and pharmacist dispensing instructions. Packaged quantity is 30 capsules, Rx only. Manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

1ecf8c84 2838 464e 87cd 96511278d9e7 09

Topiramate Extended-Release Capsules 100 mg oral dosage form label, manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label states once daily use, contains 30 capsules, and cautions to swallow the capsule whole without opening or crushing. Storage instructions and pharmacist dispensing advice are also provided. The NDC number is 68382-769-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.